These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34224155)

  • 21. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
    Khan M; Khan H; Khan S; Nawaz M
    J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
    [No Abstract]   [Full Text] [Related]  

  • 22. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recommendations for use of antigenic tests in the diagnosis of acute SARS-CoV-2 infection in the second pandemic wave: attitude in different clinical settings.
    Candel FJ; Barreiro P; San Román J; Abanades JC; Barba R; Barberán J; Bibiano C; Canora J; Cantón R; Calvo C; Carretero M; Cava F; Delgado R; García-Rodríguez J; González Del Castillo J; González de Villaumbrosia C; Hernández M; Losa JE; Martínez-Peromingo FJ; Molero JM; Muñoz P; Onecha E; Onoda M; Rodríguez J; Sánchez-Celaya M; Serra JA; Zapatero A
    Rev Esp Quimioter; 2020 Dec; 33(6):466-484. PubMed ID: 33070578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-stratified analysis of SARS-CoV-2 infection and case fatality rate in China, Italy, and South Korea.
    Liu JQ; Xu JW; Sun CY; Wang JN; Wang XT; Chen X; Gao SL
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12575-12578. PubMed ID: 33336777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Older age groups and country-specific case fatality rates of COVID-19 in Europe, USA and Canada.
    Hoffmann C; Wolf E
    Infection; 2021 Feb; 49(1):111-116. PubMed ID: 33098532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National case fatality rates of the COVID-19 pandemic.
    Ergönül Ö; Akyol M; Tanrıöver C; Tiemeier H; Petersen E; Petrosillo N; Gönen M
    Clin Microbiol Infect; 2021 Jan; 27(1):118-124. PubMed ID: 32979575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Socioeconomic position and the COVID-19 care cascade from testing to mortality in Switzerland: a population-based analysis.
    Riou J; Panczak R; Althaus CL; Junker C; Perisa D; Schneider K; Criscuolo NG; Low N; Egger M
    Lancet Public Health; 2021 Sep; 6(9):e683-e691. PubMed ID: 34252364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with SARS-CoV-2 positivity in 20 homeless shelters in Toronto, Canada, from April to July 2020: a repeated cross-sectional study.
    Kiran T; Craig-Neil A; Das P; Lockwood J; Wang R; Nathanielsz N; Rosenthal E; Snider C; Hwang SW
    CMAJ Open; 2021; 9(1):E302-E308. PubMed ID: 33785478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China.
    Porcheddu R; Serra C; Kelvin D; Kelvin N; Rubino S
    J Infect Dev Ctries; 2020 Feb; 14(2):125-128. PubMed ID: 32146445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spatial modeling, risk mapping, change detection, and outbreak trend analysis of coronavirus (COVID-19) in Iran (days between February 19 and June 14, 2020).
    Pourghasemi HR; Pouyan S; Heidari B; Farajzadeh Z; Fallah Shamsi SR; Babaei S; Khosravi R; Etemadi M; Ghanbarian G; Farhadi A; Safaeian R; Heidari Z; Tarazkar MH; Tiefenbacher JP; Azmi A; Sadeghian F
    Int J Infect Dis; 2020 Sep; 98():90-108. PubMed ID: 32574693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 in children: analysis of the first pandemic peak in England.
    Ladhani SN; Amin-Chowdhury Z; Davies HG; Aiano F; Hayden I; Lacy J; Sinnathamby M; de Lusignan S; Demirjian A; Whittaker H; Andrews N; Zambon M; Hopkins S; Ramsay ME
    Arch Dis Child; 2020 Dec; 105(12):1180-1185. PubMed ID: 32796006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 testing in North Carolina: Racial, ethnic, and geographic disparities.
    Brandt K; Goel V; Keeler C; Bell GJ; Aiello AE; Corbie-Smith G; Wilson E; Fleischauer A; Emch M; Boyce RM
    Health Place; 2021 May; 69():102576. PubMed ID: 33915376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics of patients infected with SARS-CoV-2 in North Wollo Zone, North-East Ethiopia.
    Geteneh A; Alemnew B; Tadesse S; Girma A
    Pan Afr Med J; 2021; 38():217. PubMed ID: 34046123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating effective infection fatality rates during the course of the COVID-19 pandemic in Germany.
    Staerk C; Wistuba T; Mayr A
    BMC Public Health; 2021 Jun; 21(1):1073. PubMed ID: 34090392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic and features of SARS-CoV-2 infection in Gabon.
    Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
    Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.
    Reuter M; Rigó M; Formazin M; Liebers F; Latza U; Castell S; Jöckel KH; Greiser KH; Michels KB; Krause G; Albrecht S; Öztürk I; Kuss O; Berger K; Lampl BMJ; Leitzmann M; Zeeb H; Starke KR; Schipf S; Meinke-Franze C; Ahrens W; Seidler A; Klee B; Pischon T; Andreas Deckert AD; Schmidt B; Mikolajczyk R; Karch A; Bohn B; Brenner H; Holleczek B; Dragano N
    Scand J Work Environ Health; 2022 Sep; 48(7):588-590. PubMed ID: 36153787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delay-adjusted age- and sex-specific case fatality rates for COVID-19 in South Korea: Evolution in the estimated risk of mortality throughout the epidemic.
    Newall AT; Leong RNF; Nazareno A; Muscatello DJ; Wood JG; Kim WJ
    Int J Infect Dis; 2020 Dec; 101():306-311. PubMed ID: 33011281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sex/gender differences in COVID-19 lethality: what the data say, and do not say].
    Mangia C; Russo A; Civitelli S; Gianicolo EAL
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):400-406. PubMed ID: 33412835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Derivation and Internal Validation of a Model to Predict the Probability of Severe Acute Respiratory Syndrome Coronavirus-2 Infection in Community People.
    van Walraven C; Manuel DG; Desjardins M; Forster AJ
    J Gen Intern Med; 2021 Jan; 36(1):162-169. PubMed ID: 33107007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.